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GMP = multifactorial 
 GMP quantification?  “MARKERS”
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EMA inspection: 40 dimensions  9th dimension: chemical contamination
(EU-GMP chapters 3 and 5)
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Establishment of a new GMP-marker: residual API on the packaging
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as one of the most vulnerable medicines worldwide
ARTEMETHER
Swabbing
The swabbing area was marked (25 cm²)
+ swabbed using cotton wool wetted with methanol
The swab was transferred to Erlenmeyer flask
+ 10.0 mL methanol was added
+ shaken for 30 minutes
The swab was removed from flask
+ solvent was evaporated using N2-gas
The residue was dissolved in 3.0 mL methanol
+ 0.5 mL was centrifuged for 5 min at 20 000 rpm
An aliquot of the supernatant was analysed using UHPLC-MS
UHPLC-MS
• UHPLC-Single Quadrupole MS analysis
• Acquity UPLC BEH Shield RP18 column (2.1 x 100 mm, 1.7 µm)
• Gradient: 
A: 10/90 MeOH/(ammonium acetate 10 mM + 0.1% acetic acid)
B: 95/5 MeOH/(ammonium acetate 10 mM + 0.1% acetic acid)
0-3 min: 85% A, 3.1 min: 5.9% A, 5 min: 5.9% A, 6 min: 0% A, 
7 min: 85% A, 10 min: 85% A
• Method verification: 
Recovery, linearity, accuracy & precision, analytical stability
Recovery on primary packaging of different brands. Each sample was swabbed 3 times. 
After the 3rd swab, each bottle was spiked, so that 42 ng/cm² 
would be present on the surface.
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Amount of artemether found on swabs (n = 3). Dots of the same shape
are measurements of samples with the same brand name and manufacturer.
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Total amount of artemether on the samples (paediatric bottles) after 3 swab cycles.
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Information elements unclear/missing
GMP-relation: total amount of artemether on the samples (paediatric bottles) 
against the number of information elements that were missing or unclear
(WHO checklist).
Our results indicate that residual API on the
primary packaging can be a valuable GMP-
marker, as well as to assess its biological
significance (resistance, toxicity, environmental).CO
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